Trace Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $8.33M

  • Investors
  • 12

Trace Biosciences General Information

Description

Developer of nerve-targeted fluorescent contrast agents designed to guide surgeries and eliminate surgical nerve damage. The company's agents provide direct highlighting of nerves during surgery in real-time and visualization of nerves buried beneath the surface with high contrast over other tissues, enabling surgeons to see and preserve nerves during critical surgeries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1800 North West
  • 167th Place, Suite 160
  • Beaverton, OR 97006
  • United States
+1 (971)
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1800 North West
  • 167th Place, Suite 160
  • Beaverton, OR 97006
  • United States
+1 (971)

Trace Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trace Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series A) 30-Jul-2026 $8.33M Completed Clinical Trials - Phase 2
12. Accelerator/Incubator 01-May-2024 Completed Clinical Trials - Phase 2
11. Grant 30-Apr-2024 Completed Clinical Trials - Phase 2
10. Grant 01-Apr-2024 Completed Clinical Trials - Phase 2
9. Grant 15-Sep-2023 Completed Startup
8. Grant 23-Jun-2023 Completed Startup
7. Seed Round 30-Apr-2023 Completed Startup
6. Grant 01-Oct-2022 Completed Startup
5. Grant 01-Sep-2021 $150K $400K Completed Startup
4. Grant 01-Sep-2021 $1.16M $400K Completed Startup
To view Trace Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Trace Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nerve-targeted fluorescent contrast agents designed to guide surgeries and eliminate surgical nerve damage.
Surgical Devices
Beaverton, OR
10 As of 2025

La Jolla, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trace Biosciences Competitors (2)

One of Trace Biosciences’s 2 competitors is Alume Biosciences, a Venture Capital-Backed company based in La Jolla, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alume Biosciences Venture Capital-Backed La Jolla, CA
Illuminare Biotechnologies Venture Capital-Backed New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

Trace Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trace Biosciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axogen Corporation Minority
Oregon Bioscience Incubator Accelerator/Incubator
National Institutes of Neurological Disorders and Stroke Government
Life Science Washington Accelerator/Incubator
ARPA-H Government
You’re viewing 5 of 12 investors. Get the full list »

Trace Biosciences FAQs

  • When was Trace Biosciences founded?

    Trace Biosciences was founded in 2019.

  • Where is Trace Biosciences headquartered?

    Trace Biosciences is headquartered in Beaverton, OR.

  • What is the size of Trace Biosciences?

    Trace Biosciences has 10 total employees.

  • What industry is Trace Biosciences in?

    Trace Biosciences’s primary industry is Surgical Devices.

  • Is Trace Biosciences a private or public company?

    Trace Biosciences is a Private company.

  • What is Trace Biosciences’s current revenue?

    The current revenue for Trace Biosciences is .

  • How much funding has Trace Biosciences raised over time?

    Trace Biosciences has raised $9M.

  • Who are Trace Biosciences’s investors?

    Axogen, Oregon Bioscience Incubator, National Institutes of Neurological Disorders and Stroke, Life Science Washington, and ARPA-H are 5 of 12 investors who have invested in Trace Biosciences.

  • Who are Trace Biosciences’s competitors?

    Alume Biosciences and Illuminare Biotechnologies are competitors of Trace Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process